Weight Management & Incretin Agonists
Dual and triple incretin agonists (Retatrutide 10mg/20mg, Tirzepatide 10mg, Tesamorelin 10mg) for lipolysis and energy homeostasis research.
Dual and triple incretin receptor agonists (Retatrutide 10mg/20mg, Tirzepatide 10mg, Tesamorelin 10mg) studied for energy homeostasis, thermogenesis, and adipocyte modulation across Europe.
Weight Management & Incretin Agonists
Bacteriostatic Water 10 mL
Bacteriostatic Water 10 mL is a sterile, non-pyrogenic laboratory diluent containing 0.9% benzyl alcohol as a bacteriostatic preservative. Essential across European research laboratories for reconstituting lyophilized peptides and biochemical reference standards with multi-withdrawal stability.
BPC-157 10mg | TB-500 10mg Blend
BPC-157 10mg | TB-500 10mg (20mg total lyophilized blend) is a premier synergistic research peptide stack engineered to investigate tissue repair, angiogenesis, cellular actin migration, and inflammatory modulation across European laboratories.
Retatrutide 10mg (Triple Agonist)
Retatrutide 10mg (LY3437943) is a cutting-edge triple hormone receptor agonist research peptide targeting GLP-1, GIP, and glucagon receptors (GCGR) for advanced metabolic, lipid oxidation, and energy expenditure studies in Europe.
Retatrutide 20mg (High-Capacity Vial)
Retatrutide 20mg provides double the quantity of the LY3437943 triple hormone receptor agonist (GLP-1, GIP, and Glucagon receptors) in a single sterile vial—ideal for extended European metabolic research protocols.
Tesamorelin 10mg (Stabilized GHRH Analog)
Tesamorelin 10mg is a 44-amino-acid human GHRH analog modified with a trans-3-hexenoic acid group for enhanced DPP-4 enzymatic resistance, widely studied in European metabolic and visceral lipolysis research.
Tirzepatide 10mg (Dual GIP/GLP-1 Agonist)
Tirzepatide 10mg (LY3298176) is a high-purity 39-amino-acid dual GIP and GLP-1 receptor agonist peptide utilized across European research laboratories for investigating incretin signaling, glucose homeostasis, and energy balance.
Incretin Agonists & Weight Management Research Peptides in Europe
Scientific investigation into neuroendocrine satiety signaling, adipocyte lipolysis, and brown adipose tissue (BAT) thermogenesis relies on high-purity receptor agonists. Our Weight Management & Incretin Agonists category supplies European research laboratories with ≥99.0% HPLC-verified multi-receptor peptides.
Primary Compounds for Adipocyte & Energy Homeostasis Studies
- Triple Agonists (GLP-1R / GIPR / GCGR): Retatrutide 10mg and Retatrutide 20mg combine incretin receptor activation with glucagon-mediated energy expenditure modeling.
- Dual GIP/GLP-1 Co-Agonist: Tirzepatide 10mg is widely utilized in comparative studies on insulin sensitivity and lipid mobilization.
- Visceral Lipolysis via GHRH Signaling: Tesamorelin 10mg supports specialized research into somatotropic regulation of visceral adipose tissue.